Market Overview

Sage Therapeutics (NASDAQ: SAGE)

35.72 -1.66 (-4.44%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/26/20RBC CapitalReiteratesOutperform75.0
5/08/20WedbushDowngradesNeutral37.0
5/08/20SunTrust Robinson HumphreyMaintainsHold35.0
5/08/20RBC CapitalMaintainsOutperform72.0
4/28/20RBC CapitalMaintainsOutperform71.0
4/09/20SunTrust Robinson HumphreyMaintainsHold37.0
4/09/20BMO CapitalMaintainsOutperform65.0
4/08/20Canaccord GenuityMaintainsBuy80.0
4/08/20CitigroupMaintainsBuy54.0
4/08/20RBC CapitalMaintainsOutperform68.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter